Muller Fabbri, MD, PhD, served as the sole editor of the recently published book, “Non-coding RNAs and Cancer.” From identifying the physiology of cancer biomarkers to the collection and analysis of genetic data, this book leads researchers through the multifactorial interaction between non-coding RNAs and cancer development. The book specifically examines the role of microRNAs in regulating gene expression during carcinogenesis and reveals unexpected functions of these particular non-coding RNAs. These new discoveries will lead to the identification of molecular anticancer targets for cancer therapy, and may revolutionize the way physicians treat and care for cancer patients.
Skorn Ponrartana, MD, MPH, focuses on imaging children from the fetal period to early childhood to identify potential pediatric biomarkers that predict later disease in life. Specifically, he is using nonionizing MRI to safely examine placental morphology and the development of fetal characteristics through birth and infancy. The early identification of disease markers may serve as a way to predict the later development of pervasive public health conditions, such as cardiovascular disease and diabetes.
Senta Georgia, PhD, from the Division of Endocrinology and Metabolism, was recently accepted into the 2014 Fellows Program of the Keystone Symposia on Molecular and Cellular Biology. This program is dedicated to enhancing the participation and understanding of life-science research, and graduates emerge as knowledgeable and active members of the scientific community. The Keystone Symposia Fellows Program focuses on exposing participants to how research selections are made, how conferences are organized and how research agendas are set.
Six researchers from The Saban Research Institute of Children’s Hospital Los Angeles and the Keck School of Medicine of the University of Southern California (USC) were recently selected to join the Society for Pediatric Research.
In a ground-breaking study, Anat Erdreich-Epstein, MD, PhD, and colleagues from The Saban Research Institute of Children’s Hospital Los Angeles, are the first to link the level of messenger RNA of the gene PID1 to clinical outcomes of patients with two important types of brain cancer: medulloblastomas and gliomas.
A bill, known as the National Pediatric Research Network Act and strongly supported by Children’s Hospital Los Angeles, passed the U.S. Senate Thursday night by unanimous voice vote, two days after passing the House of Representatives in similar fashion.